![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Researchers have developed a miniature synchrotron that could enable researchers to conduct protein crystallography experiments in their own university and 'revolutionise the way science is done'... Read Invitrogen 'clicks' with Harvard for assay tech Invitrogen has exclusively licensed 'click chemistry' technology from Harvard University that greatly simplifies the fluorescent-labelling of biomolecules for use in proliferation assays... Read Industry news in brief - week 50 LabTechnologist.com brings you a periodic update of recent industry news with developments at EMD Chemicals, MicroCal, Oxford Gene Technology, Protagen, Syrris and Varian... Read Roche targets Ventana's board to force takeover The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Carl Zeiss licenses 'record-breaking' fluorescence technology Microscopy expert-Carl Zeiss has licensed a new fluorescence microscopy technique that enables scientists to determine the precise intracellular location of proteins of interest... Read |
|||||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds SeQuant is introducing a new ZIC®-HILIC column for ultra-high speed applications. Its potential is illustrated by a complete baseline separation of Oseltamavir (Tamiflu®) from Oseltamavir Carboxylate followed by MS/MS detection in less than 40 seconds... Click Here | |||||||||||||||||
|
Related Industry News NNE wins Pronova contract NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark... Read GSK allies with OncoMed to beat cancer stem cells GlaxoSmithKline (GSK) and OncoMed are teaming up to develop novel antibody therapies that target the cancer stem cells believed to play a key role in forming cancers... Read Transport wins for elecrokinetic drug delivery Transport Pharmaceuticals has been named the 2007 North American Technology Innovation of the Year Award winner in electrokinesis-enabled drug delivery... Read Eisai continues biologics push with $3.9bn MGI Pharma buy Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||